Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.12 USD | -2.77% | -2.37% | -22.49% |
03:16pm | Sector Update: Health Care Stocks Steady Premarket Thursday | MT |
02:52pm | Biogen, Ionis to Cease BIIB105 ALS Investigational Drug Development Following Phase 1/2 Trial Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.49% | 5.72B | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.07% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- IONS Stock
- News Ionis Pharmaceuticals, Inc.
- Stifel Adjusts Price Target on Ionis Pharmaceuticals to $50 From $45, Maintains Hold Rating